XML 14 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Retained Earnings
Balance (in shares) at Sep. 30, 2022   35,724,057        
Balance at Sep. 30, 2022 $ 154,536 $ 36 $ 258,275   $ (10,285) $ (30,936)
Balance (in shares) at Sep. 30, 2022       (3,813,199)    
Increase (Decrease) in Stockholders' Equity            
Net income 3,967         3,967
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units (in shares)   190,119        
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units 495   495      
Taxes paid associated with net settlement of stock compensation awards (in shares)   (14,536)        
Taxes paid associated with net settlement of stock compensation awards (244)   (244)      
Common stock repurchased (7,199)     $ (7,199)    
Common stock repurchased (in shares)       (531,819)    
Stock compensation expense 2,126   2,126      
Balance (in shares) at Dec. 31, 2022   35,899,640        
Balance at Dec. 31, 2022 154,953 $ 36 260,653   (9,012) (26,970)
Balance (in shares) at Dec. 31, 2022       (4,345,018)    
Balance (in shares) at Sep. 30, 2022   35,724,057        
Balance at Sep. 30, 2022 154,536 $ 36 258,275   (10,285) (30,936)
Balance (in shares) at Sep. 30, 2022       (3,813,199)    
Increase (Decrease) in Stockholders' Equity            
Net income 14,698          
Balance (in shares) at Jun. 30, 2023   36,115,562        
Balance at Jun. 30, 2023 155,809 $ 36 264,162   (8,124) (16,238)
Balance (in shares) at Jun. 30, 2023       (5,432,546)    
Balance (in shares) at Dec. 31, 2022   35,899,640        
Balance at Dec. 31, 2022 154,953 $ 36 260,653   (9,012) (26,970)
Balance (in shares) at Dec. 31, 2022       (4,345,018)    
Increase (Decrease) in Stockholders' Equity            
Net income 4,245         4,245
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units (in shares)   184,791        
Taxes paid associated with net settlement of stock compensation awards (in shares)   (34,713)        
Taxes paid associated with net settlement of stock compensation awards (492)   (492)      
Common stock repurchased (9,814)     $ (9,814)    
Common stock repurchased (in shares)       (749,903)    
Stock compensation expense 1,939   1,939      
Balance (in shares) at Mar. 31, 2023   36,049,718        
Balance at Mar. 31, 2023 151,074 $ 36 262,118   (8,769) (22,725)
Balance (in shares) at Mar. 31, 2023       (5,096,341)    
Increase (Decrease) in Stockholders' Equity            
Net income 6,487         6,487
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units (in shares)   87,515        
Taxes paid associated with net settlement of stock compensation awards (in shares)   (21,671)        
Taxes paid associated with net settlement of stock compensation awards (324)   (324)      
Common stock repurchased (4,268)     $ (4,268)    
Common stock repurchased (in shares)       (325,410)    
Shares swapped to exercise stock options     173 $ (173)    
Shares swapped to exercise stock options (in shares)       (10,795)    
Stock compensation expense 2,195   2,195      
Balance (in shares) at Jun. 30, 2023   36,115,562        
Balance at Jun. 30, 2023 $ 155,809 $ 36 264,162   (8,124) (16,238)
Balance (in shares) at Jun. 30, 2023       (5,432,546)    
Balance (in shares) at Sep. 30, 2023 36,142,346 36,142,345        
Balance at Sep. 30, 2023 $ 161,533 $ 36 265,945 $ (84,031) (10,458) (9,958)
Balance (in shares) at Sep. 30, 2023 5,433,045     (5,433,045)    
Increase (Decrease) in Stockholders' Equity            
Net income $ 1,907         1,907
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units (in shares)   59,471        
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units 127   127      
Taxes paid associated with net settlement of stock compensation awards (in shares)   (12,058)        
Taxes paid associated with net settlement of stock compensation awards (224)   (224)      
Common stock repurchased (1,171)     $ (1,171)    
Common stock repurchased (in shares)       (68,692)    
Stock compensation expense 2,249   2,249      
Foreign currency translation 958       958  
Balance (in shares) at Dec. 31, 2023   36,189,758        
Balance at Dec. 31, 2023 $ 165,379 $ 36 268,096 $ (85,202) (9,500) (8,051)
Balance (in shares) at Dec. 31, 2023       (5,501,737)    
Balance (in shares) at Sep. 30, 2023 36,142,346 36,142,345        
Balance at Sep. 30, 2023 $ 161,533 $ 36 265,945 $ (84,031) (10,458) (9,958)
Balance (in shares) at Sep. 30, 2023 5,433,045     (5,433,045)    
Increase (Decrease) in Stockholders' Equity            
Net income $ 13,616          
Balance (in shares) at Jun. 30, 2024 36,525,606 36,525,606   (5,997,932)    
Balance at Jun. 30, 2024 $ 171,970 $ 36 271,825 $ (93,482) (10,067) 3,658
Balance (in shares) at Jun. 30, 2024 5,997,932          
Balance (in shares) at Dec. 31, 2023   36,189,758        
Balance at Dec. 31, 2023 $ 165,379 $ 36 268,096 $ (85,202) (9,500) (8,051)
Balance (in shares) at Dec. 31, 2023       (5,501,737)    
Increase (Decrease) in Stockholders' Equity            
Net income 5,709         5,709
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units (in shares)   353,069        
Taxes paid associated with net settlement of stock compensation awards (in shares)   (66,464)        
Taxes paid associated with net settlement of stock compensation awards (1,142)   (1,142)      
Common stock repurchased (7,907)     $ (7,907)    
Common stock repurchased (in shares)       (473,953)    
Stock compensation expense 2,343   2,343      
Foreign currency translation (457)       (457)  
Balance (in shares) at Mar. 31, 2024   36,476,363        
Balance at Mar. 31, 2024 163,925 $ 36 269,297 $ (93,109) (9,957) (2,342)
Balance (in shares) at Mar. 31, 2024       (5,975,690)    
Increase (Decrease) in Stockholders' Equity            
Net income 6,000         6,000
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units (in shares)   53,921        
Taxes paid associated with net settlement of stock compensation awards (in shares)   (4,678)        
Taxes paid associated with net settlement of stock compensation awards (89)   (89)      
Common stock repurchased (373)     $ (373)    
Common stock repurchased (in shares)       (22,242)    
Stock compensation expense 2,617   2,617      
Foreign currency translation $ (110)       (110)  
Balance (in shares) at Jun. 30, 2024 36,525,606 36,525,606   (5,997,932)    
Balance at Jun. 30, 2024 $ 171,970 $ 36 $ 271,825 $ (93,482) $ (10,067) $ 3,658
Balance (in shares) at Jun. 30, 2024 5,997,932